AkzoNobel Axalta Merger Creates $25 Billion Coatings Giant
AkzoNobel Axalta merger will create a NYSE-listed coatings firm and prompt repricing around $600 million synergies, leverage, and capital-return plans.
KEY TAKEAWAYS
- All-stock merger sets exchange ratio at 0.6539 AkzoNobel shares per Axalta share.
- Pro forma company targets $3.3 billion adjusted EBITDA and $1.5 billion adjusted free cash flow.
- Deal aims for $600 million pre-tax synergies and a net leverage target of 2.0x-2.5x.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
AkzoNobel and Axalta Coating Systems will merge to form a global coatings company with about $17 billion in combined annual revenue and targeted pre-tax run-rate synergies of $600 million, the companies said in a joint press release on Nov. 18, 2025.
Deal Terms, Financial Targets, and Capital Structure
AkzoNobel N.V. and Axalta Coating Systems (AXTA) agreed to an all-stock merger of equals under which Axalta shareholders will receive 0.6539 AkzoNobel shares for each Axalta share. Both boards unanimously approved the deal, and both companies have suspended share buybacks. AkzoNobel will pay a special cash dividend of €2.5 billion minus Axalta’s net debt at closing to its shareholders. This exchange ratio, dividend, and halted buybacks reshape the near-term capital-return profile for both sets of shareholders.
The combined company targets $3.3 billion of adjusted EBITDA, a proxy for operating profit, and $1.5 billion of adjusted free cash flow. Management aims for an EBITDA margin approaching 20% and a net leverage ratio between 2.0 and 2.5 times. About 90% of the $600 million synergy target is expected within three years, driven by procurement, selling, general and administrative expenses, footprint optimization, and supply-chain savings. Regular dividends will continue under existing policy until closing. The projected cash generation and leverage range are central to the combined group’s operating and capital-allocation plans.
Governance, Listing, and Transaction Timeline
Rakesh Sachdev will chair the board. AkzoNobel CEO Greg Poux-Guillaume will serve as chief executive of the combined company, with Axalta CEO Chris Villavarayan as deputy CEO and Axalta CFO Carl Anderson as CFO. Poux-Guillaume said, “This merger will allow us to accelerate our growth ambitions by bringing together highly complementary technologies, expertise and passionate people to unlock our full combined potential.”
The merged company will be dual-headquartered in Amsterdam and Philadelphia under a Dutch holding company with tax residency in the Netherlands. The combined shares will be listed solely on the New York Stock Exchange after a dual-listing transition period, pending NYSE authorization. Extraordinary general meetings to seek shareholder approval are expected mid-2026. The transaction is targeted to close in late 2026 to early 2027, subject to shareholder and regulatory approvals, works-council consultations, and customary closing conditions.
Advisers on the transaction include Evercore and J.P. Morgan Securities LLC for Axalta, the Incentrum Group on the financial side, and law firms Cravath, Swaine & Moore LLP and NautaDutilh N.V.
